Want to join the conversation?
$ECL said that 4Q15 reported EPS was $0.69 and on an adjusted basis, excluding special gains and charges and discrete tax items from both years, EPS rose 2% to $1.22 despite a $0.13 or 11% currency headwind. This growth was driven by delivered product and other cost savings, cost efficiencies, synergies, new products lower tax rate & share count.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?